Literature DB >> 6995475

Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy.

A B Gustafson, M F Banasiak, R K Kalkhoff, T C Hagen, H J Kim.   

Abstract

Plasma glucose and insulin concentrations were measured during oral glucose and iv tolbutamide tolerance tests in nine women with hyperprolactinemia and the amenorrheagalactorrhea syndrome (AGS). Glucose tolerance curves, basal insulin levels, and postchallenge plasma insulin responses were significantly higher in AGS women compared to those in an age- and weight-matched control group. Fasting plasma glucagon concentrations were unaltered in AGS, but suppression of the hormone after oral glucose was greater and more prolonged relative to the control response. Oral glucose tolerance tests were performed on nine normal women during late pregnancy who had physiological hyperprolactinemia comparable to that in the AGS group. Glucose tolerance curves, exaggerated plasma insulin responses, and glucagon suppression resembled those observed in the AGS women. These results suggest that elevated plasma PRL concentrations may contribute to the development of hyperinsulinemia and accentuated glucagon suppression in response to glucose that is characteristic of late human pregnancy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995475     DOI: 10.1210/jcem-51-2-242

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.

Authors:  Serap Soytac Inancli; Alper Usluogullari; Yusuf Ustu; Sedat Caner; Abbas Ali Tam; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-12-12       Impact factor: 3.633

2.  In vivo insulin antagonism but evanescent in vitro tissue effect in rats with growth hormone-secreting tumors.

Authors:  M B Davidson; D C Shen; N Venkatesan; G Sladen
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

3.  Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.

Authors:  J E de Leeuw van Weenen; E T Parlevliet; J P Schröder-van der Elst; S A van den Berg; K Willems van Dijk; J A Romijn; H Pijl
Journal:  Exp Diabetes Res       Date:  2011-04-06

4.  Insulin sensitivity and hyperprolactinemia.

Authors:  A Tuzcu; M Bahceci; M Dursun; C Turgut; S Bahceci
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

5.  Chronic hyperprolactinemia and plasma lipids in women.

Authors:  H M Heshmati; G Turpin; J L de Gennes
Journal:  Klin Wochenschr       Date:  1987-06-01

6.  Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.

Authors:  Alpaslan Tuzcu; Serkan Yalaki; Senay Arikan; Deniz Gokalp; Mithat Bahcec; Sadiye Tuzcu
Journal:  Pituitary       Date:  2009-05-01       Impact factor: 4.107

7.  Metabolic changes in the rat liver during pregnancy. II. Tricarboxylic acid cycle.

Authors:  P Brockerhoff; J M Klug; R Rosskopf; M Höckel; K H Schicketanz; G H Rathgen
Journal:  Arch Gynecol       Date:  1983

Review 8.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.

Authors:  G Schernthaner; R Prager; C Punzengruber; A Luger
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

10.  Hepatocyte insulin binding and action in rats with somatomammotrophic tumours.

Authors:  M B Davidson; S Melmed
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.